Merrimack Pharmaceuticals, Inc. (MACK)
$12.37
+0.01 (+0.08%)
Rating:
Recommendation:
Neutral
| Symbol | MACK |
|---|---|
| Price | $12.37 |
| Beta | 1.724 |
| Volume Avg. | 0.08M |
| Market Cap | 177.151M |
| Shares () | - |
| 52 Week Range | 3.0-13.66 |
| 1y Target Est | - |
| DCF Unlevered | MACK DCF -> | |
|---|---|---|
| DCF Levered | MACK LDCF -> | |
| ROE | -7.34% | Neutral |
| ROA | -6.66% | Neutral |
| Operating Margin | - | |
| Debt / Equity | - | |
| P/E | -112.45 | Strong Sell |
| P/B | 9.29 | Strong Buy |
Latest MACK news
About
Download (Excel)Mr. Gary L. Crocker M.B.A., MBA
Healthcare
Biotechnology
NASDAQ Global Market
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.